Pharmacokinetics of apixaban in patients with short bowel syndrome: a Bayesian re-estimation approach

Authors

Institutions

Publication Details

Journal
Expert Opinion on Drug Metabolism & Toxicology
Published
2025-09-29
DOI
https://doi.org/10.1080/17425255.2025.2562047
Citations
1
Primary Topic
Gastroesophageal reflux and treatments
Type
article
Field-Weighted Citation Impact
1.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacokinetics of apixaban in patients with short bowel syndrome: a Bayesian re-estimation approach

Ondřej Slanař, Petr Kozlík, Danica Michaličková, Elke H. J. Krekels et al.
1 citations
Expert Opinion on Drug Metabolism & Toxicology
Gastroesophageal reflux and treatments
1.81
article

Pharmacokinetics of apixaban in patients with short bowel syndrome: a Bayesian re-estimation approach

Ondřej Slanař, Petr Kozlík, Danica Michaličková, Elke H. J. Krekels, Olga Bartošová, Karolína Hronová, Irena Netíková, František Novák, Eva Meisnerová
article en
1 citations

Abstract

No abstract available for this paper.
Expert Opinion on Drug Metabolism & ToxicologyVol. 21(10)
Leiden University (NL), Charles University (CZ), Certara (United States) (US), General University Hospital in Prague (CZ)
Openalex Percentile: Top 13%
Gastroesophageal reflux and treatments
1.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.